Kevin S. Richter

Kevin S. Richter

Auto-generated profile, based on publicly available information

Kevin S. Richter

Fertility Science Consulting, Silver Spring, MD

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Fertility and Sterility
Verified
Journal Article
Closed access
KRKevin S. Richter
Kevin S. Richter
KBKathleen R. Bugge
Kathleen R. Bugge
JBJason G. Bromer
Jason G. Bromer
MLMichael J. Levy
Michael J. Levy

1 October 2006 in Fertility and Sterility
Verified
Journal Article
Closed access
KRKevin S. Richter
Kevin S. Richter
SSSharon K. Shipley
Sharon K. Shipley
IMIngrid McVearry
Ingrid McVearry
MTMichael J. Tucker
Michael J. Tucker
EWEric A. Widra
Eric A. Widra

1 June 2008 in Current Opinion in Obstetrics and Gynecology
Verified
Journal Article
Closed access
KRKevin S Richter
Kevin S Richter
The present paper reviews evidence that preimplantation embryos are naturally exposed and designed to respond to growth factors during preimplantation development. Recent studies have demonstrated that in-vivo human preimplantation embryos are exposed to a mixture of many different growth factors, expressed by the follicles, oviducts and endometrium. Receptors for many of these growth factors have also been shown to be expressed by preimplantation embryos, suggesting a functional role during preimplantation development. Studies of in-vitro fertilization in both animals and humans indicate that in-vitro culture of embryos in conventional media lacking growth factors can result in suboptimal growth and a variety of short-term and long-term developmental abnormalities. Studies of embryo coculture indirectly suggest that growth factors can improve in-vitro development. Many studies of defined growth factor supplements demonstrate that their inclusion in culture media can substantially improve preimplantation development and efficacy of in-vitro fertilization, and may reduce long-term developmental abnormalities as well. Embryos are naturally exposed to a complex mixture of growth factors that play an important role in preimplantation embryo development and that are likely to be of substantial benefit if added to in-vitro culture media.

1 August 2016 in Fertility and Sterility
Verified
Journal Article
Closed access
KRKevin S. Richter
Kevin S. Richter
DGDaniella K. Ginsburg
Daniella K. Ginsburg
SSSharon K. Shipley
Sharon K. Shipley
JLJosh Lim
Josh Lim
MTMichael J. Tucker
Michael J. Tucker
MLMichael J. Levy
Michael J. Levy

1 May 2019 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
MCMatthew T. Connell
Matthew T. Connell
KRKevin S. Richter
Kevin S. Richter
KDKate Devine
Kate Devine
MHMicah J. Hill
Micah J. Hill
ADAlan H. DeCherney
Alan H. DeCherney
MLMichael J. Levy
Michael J. Levy

29 April 2023 in Human Reproduction
Verified
Journal Article
Open access
PDF file
KRKevin S Richter
Kevin S Richter
MRMartin L Richter
Martin L Richter
After more than a decade of increasingly widespread clinical use, personalized embryo transfer guided by endometrial receptivity analysis (ERA) remains controversial and unproven. One key element missing from the historical literature is the recognition that potential benefits from personalized embryo transfer are entirely dependent on the accuracy and predictive value of the ERA test. Results from the first comprehensive clinical trial, designed in a way that allowed independent evaluation of both potential benefits of personalized embryo transfer and the predictive value of the ERA test upon which it is based, were recently published. However, the authors failed to conduct an appropriate analysis or recognize the significance of their results. Here, we present a simple reanalysis of data from this otherwise excellent randomized controlled trial, demonstrating for the first time that the ERA was unable to identify the window of implantation as purported and that, as a result, personalized embryo transfer based on the ERA actually reduced rather than increased the birth rates. Based on these results and the lack of any contradictory evidence, it is our opinion that all clinical use of ERA-guided personalized embryo transfer should be discontinued immediately, outside of a controlled experimental setting with appropriate informed consent of all participating patients.